MedTrace Logo

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

NCT07698886 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-08-06

No results posted yet for this study

Summary

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Conditions

  • HPV (Human Papillomavirus)-Associated
  • Genital Warts

Interventions

DRUG

Geniwa gel

Geniwa gel contains alpha lactalbumin-oleic acid 5%

OTHER

Placebo gel

Placebo gel contains saline

Sponsors & Collaborators

  • KTH Biopharma

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-16
Primary Completion
2027-08-15
Completion
2027-09-15

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698886 on ClinicalTrials.gov